Literature DB >> 16039292

Elevated skin tissue cholesterol levels and myocardial infarction.

Dennis L Sprecher1, Gregory L Pearce.   

Abstract

BACKGROUND: Skin cholesterol has been associated with coronary artery disease, extent of angiographic disease and inflammatory markers such as hs-CRP. Based on these findings we sought to determine whether skin cholesterol was associated with myocardial infarction (MI).
METHODS: Patients (N = 649) underwent diagnostic catheterization and concurrent skin cholesterol measurement. History of MI was determined at the time of hospitalization.
RESULTS: Patients with a history of MI (n = 225, 35%) had significantly higher skin cholesterol than those without MI (127+/-29 versus 120+/-20, p = 0.002). The odds ratio for high skin cholesterol (for MI) was 1.6 (95% CI = 1.1, 2.6; p = 0.01) after adjustment for traditional risk and extent of angiographic disease.
CONCLUSION: Skin cholesterol may indicate increased risk of coronary-related events rather than simply the presence of angiographic narrowing.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16039292     DOI: 10.1016/j.atherosclerosis.2005.01.022

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  3 in total

Review 1.  The outer frontier: the importance of lipid metabolism in the skin.

Authors:  Kenneth R Feingold
Journal:  J Lipid Res       Date:  2008-10-31       Impact factor: 5.922

2.  Non-invasive skin cholesterol testing: a potential proxy for LDL-C and apoB serum measurements.

Authors:  Jiacheng Lai; Yongsheng Han; Chongjian Huang; Bin Li; Jingshu Ni; Meili Dong; Yikun Wang; Qingtong Wang
Journal:  Lipids Health Dis       Date:  2021-10-17       Impact factor: 3.876

3.  Structural and Functional Analysis of Excised Skins and Human Reconstructed Epidermis with Confocal Raman Spectroscopy and in Microfluidic Diffusion Chambers.

Authors:  Dorottya Kocsis; Hichem Kichou; Katalin Döme; Zsófia Varga-Medveczky; Zsolt Révész; Istvan Antal; Franciska Erdő
Journal:  Pharmaceutics       Date:  2022-08-13       Impact factor: 6.525

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.